Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Not Confirmed
Not Confirmed
28-30 September, 2024
Discovery on TargetDiscovery on Target
Not Confirmed
Not Confirmed
30 September-03 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Industry Trade Show
Not Confirmed
28-30 September, 2024
Discovery on TargetDiscovery on Target
Industry Trade Show
Not Confirmed
30 September-03 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
17 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/scitech-development-inc-announces-receipt-of-drug-supply-from-the-national-cancer-institute-nci-302249654.html
12 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/12/2945069/0/en/Biosplice-Therapeutics-Announces-Initiation-of-Acute-Myeloid-Leukemia-AML-and-Myelodysplastic-Syndromes-MDS-Trial-Sponsored-by-the-National-Cancer-Institute-NCI.html
21 May 2024
// BUSINESSWIRE
28 Apr 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/04/28/2431533/35550/en/XBiotech-Announces-French-National-Agency-ANSM-Approval-and-National-Cancer-Institute-INSA-funding-to-Support-Phase-I-II-III-Clinical-Study-for-Natrunix-in-Combination-with-Triflur.html
19 Apr 2022
// N.P. Taylor FIERCEBIOTECH
https://www.fiercebiotech.com/biotech/il-12-prospect-nearing-clinic-ankyra-inks-nci-pact-support-cancer-pipeline-progress
19 Apr 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/04/19/2424302/0/en/NextCure-and-the-National-Cancer-Institute-Announce-Preclinical-Data-in-Journal-of-Clinical-Investigation.html
ABOUT THIS PAGE
National Cancer Institute is a supplier offers 3 products (APIs, Excipients or Intermediates).
Find a price of Bevacizumab+Rituximab bulk offered by National Cancer Institute
Find a price of 2-CYANO-3, 12-DIOXOOLEANA-1, 9(11)-DIEN-28-OIC ACID (CDDO) bulk offered by National Cancer Institute
Find a price of HUMANIZED MIK-BETA-1 MONOCLONAL ANTIBODY bulk offered by National Cancer Institute
LOOKING FOR A SUPPLIER?